Pulmonary Hypertension Trial, Recruiting NCT07561034 Sponsor: University of Rochester Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT07561034
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be a patient who receives care at the University of Rochester Medical Center Pulmonary Hypertension Clinic.
  • You must be an adult (over 18 years old) who has been diagnosed with pulmonary hypertension related to scarring or stiffening of the lungs, confirmed by a heart procedure called a right heart catheterization, and your treatment has not changed for at least 30 days.
  • You must have access to a smartphone or email to receive daily messages.
  • You must be considered medically stable by the study doctor.

Who may not be able to join:

  • You are currently pregnant.
  • Your pulmonary hypertension falls into certain specific medical categories known as Groups 1, 2, 4, or 5 (confirm with trial site).
  • Your resting heart rate was faster than 120 beats per minute during the initial screening check.
  • You are unable to walk.
  • Your pulmonary hypertension is classified as the most severe level of physical limitation, known as WHO Functional Class IV (confirm with trial site).
  • You do not have access to email or text messaging.
  • You are currently taking part in a rehabilitation program.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 585 273 4608

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 July 2026
Est. completion
30 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean Change in Cardiac Effort From Baseline to 16 Weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov